1. Home
  2. Products
  3. By Formulation Type
  4. Eye Drops
  1. Home
  2. Products
  3. By Formulation Type
  4. Eye Drops

Eye Drop Manufacturer in India

WHO-GMP certified sterile ophthalmic manufacturing — antibiotic, anti-inflammatory, antiglaucoma, lubricant, anti-allergic and immunomodulator eye drops — from a classified cleanroom facility for domestic supply, institutional procurement and international export.

Key Highlights

  • WHO-GMP Certified
    Sterile Facility

  • Classified Cleanroom
    Manufacturing

  • 15+ Countries
    Supplied

  • DCGI Approved
    Formulations

About Eye Drops

Ophthalmic manufacturing
expertise at 9M India

9M India manufactures sterile ophthalmic eye drop preparations from a WHO-GMP certified sterile manufacturing facility in Birkoni, Chhattisgarh. Our ophthalmic portfolio is one of the most comprehensive available from a single Indian manufacturer — covering antibiotic eye drops, antiviral eye drops, antifungal eye drops, anti-inflammatory eye drops, anti-allergic eye drops, antiglaucoma eye drops, lubricant/tear substitute drops, mydriatic and cycloplegic drops, miotic drops, diagnostic agents, decongestant drops and immunomodulator drops including Cyclosporine.

Ophthalmic manufacturing represents the highest sterility and precision standard in pharmaceutical production. Eye drop formulations require sterile manufacture in classified cleanroom environments, aseptic fill and finish into sterile containers, precise control of pH (6.5–7.4 for most ophthalmic preparations), osmolality (280–320 mOsm/kg), viscosity and preservative concentration. Every batch undergoes sterility testing, particulate matter analysis, pH, assay and container closure integrity testing before release.

The inclusion of specialty ophthalmic formulations — Cyclosporine (immunomodulator), Latanoprost (antiglaucoma prostaglandin analogue) and Natamycin (antifungal) — in our portfolio positions 9M India as a manufacturer of both commodity and specialty ophthalmic products. These formulations are particularly relevant for international export markets including Africa and South-East Asia.

 

  • Sterile ophthalmic manufacturing — classified cleanroom, aseptic fill-finish
  • Anti-infective, antiglaucoma, lubricant, anti-inflammatory, specialty ophthalmic drops
  • Multi-dose LDPE bottles with sterile dropper tips
  • Sterility, particulate matter, pH and osmolality testing on every batch
  • DCGI-approved — specialty formulations including Cyclosporine and Latanoprost

Enquire Now

Our Capabilities

Ophthalmic manufacturing capabilities at 9M India

  • 01

    Eye drop manufacturing at 9M India is conducted in classified cleanroom environments — Grade A/B zones for aseptic fill and finish operations, Grade C for preparation and filtration. Water for Injection (WFI) manufactured on-site from purified water via double-pass RO and final distillation. Bulk preparation in SS 316L vessels with 0.2 micron sterile filtration before fill. Aseptic filling conducted under continuous Class A laminar airflow with environmental monitoring for viable and non-viable particles. Container closure integrity tested on every filled batch.

  • 02

    Antibiotic eye drops — Moxifloxacin (4th generation fluoroquinolone), Ciprofloxacin and their combination formulations — for bacterial conjunctivitis and post-surgical prophylaxis. Antiviral eye drops — Acyclovir drops for herpes simplex keratitis. Antifungal eye drops — Natamycin 5% ophthalmic suspension, the first-line treatment for fungal keratitis and one of the most demanded specialty ophthalmic formulations in export markets. Stability of Natamycin suspension requires validated suspension manufacturing with controlled particle size to maintain uniform dose delivery.

  • 03

    Antiglaucoma eye drops represent a specialty segment requiring precise API concentrations and validated long-term stability. 9M India manufactures beta-blocker drops (Timolol), prostaglandin analogue drops (Latanoprost) — which require cold chain storage at 2–8°C until dispensed — and carbonic anhydrase inhibitor drops (Dorzolamide) and alpha- agonist drops (Brimonidine). These formulations are essential components of glaucoma management protocols in both domestic and export markets, particularly in Africa where glaucoma prevalence is high.

  • 04

    Lubricant and artificial tear formulations — Carboxymethylcellulose (CMC) drops and Hypromellose drops — are among the highest volume ophthalmic preparations in both institutional and retail pharmacy supply. Cyclosporine ophthalmic emulsion (0.05%) — an immunomodulator for dry eye disease — represents a specialty formulation requiring ophthalmic-grade emulsification and validated stability for the nanoemulsion carrier system. This is a high-value formulation with strong export market demand.

  • 05

    Complete ophthalmic documentation — Manufacturing Licence, DCGI approvals, WHO- GMP Certificate, COA (including sterility, particulate matter, pH, assay), COC, stability data and product dossiers. Cold chain management for temperature-sensitive ophthalmic formulations (Latanoprost: 2–8°C). Multi-lingual labelling and serialisation for export markets. Technical bid support for institutional procurement and government tenders including NHM ophthalmic supply programmes.

Ophthalmic categories

Ophthalmic formulations across 11 categories

  • Ophthalmic Anti-infectives

    • Antibiotic
    • Antiviral
    • Antifungal
    • Moxifloxacin
    • Ciprofloxacin
    • Acyclovir
    • Natamycin
    • Corticosteroid
    • NSAID
    • Prednisolone
    • Dexamethasone
    • Ketorolac
  • Anti-allergic

    • Antihistamine
    • Mast cell stabiliser
    • Olopatadine
    • Ketotifen
    • Sodium cromoglycate
  • Antiglaucoma

    • Beta-blocker
    • Prostaglandin analogue
    • CAI
    • Alpha-agonist
    • Timolol
    • Latanoprost
    • Dorzolamide
    • Brimonidine
  • Mydriatic & Cycloplegic

    • Atropine
    • Tropicamide
  • Lubricants / Tear Substitutes

    • CMC drops
    • Hypromellose drops
  • Immunomodulator

    • Cyclosporine ophthalmic emulsion
  • Miotic / Diagnostic / Decongestant

    • Pilocarpine
    • Fluorescein
    • Naphazoline

Why Choose Us

Why choose 9M India for
eye drop manufacturing

  • Sterile ophthalmic manufacturing. The highest standard in Indian pharma.

    Classified cleanroom, aseptic fill-finish, WFI manufacture, 0.2 micron sterile filtration — the complete sterile ophthalmic manufacturing standard. Fewer than 18% of Indian pharmaceutical plants are globally compliant. Sterile ophthalmic manufacturers represent an even smaller subset.

  • Specialty formulations — Natamycin, Cyclosporine, Latanoprost.

    Not just commodity antibiotic and lubricant eye drops — specialty formulations including Natamycin antifungal, Cyclosporine immunomodulator and Latanoprost prostaglandin antiglaucoma drops. These are the formulations that win export tenders and differentiate a manufacturer from commodity competitors.

  • 11 ophthalmic categories. Single-source supply.

    Anti-infective, antiglaucoma, lubricant, anti-inflammatory, anti-allergic, immunomodulator, mydriatic, miotic, diagnostic, decongestant and specialty formulations — all from one WHO- GMP certified ophthalmic facility. Single-source supply for the full ophthalmic range.

Our Eye Drops Range

Key eye drop formulations manufactured at 9M India

Key molecules from our injectable manufacturing portfolio — across all five therapeutic categories, three container formats and the full spectrum of institutional and export supply requirements.

  • 01

    Moxifloxacin Eye Drops | Anti-infective | Antibiotic | 5ml/10ml

  • 02

    Ciprofloxacin Eye Drops | Anti-infective | Antibiotic | 5ml/10ml

  • 03

    Natamycin Eye Drops | Anti-infective | Antifungal | 5ml

  • 04

    Prednisolone Eye Drops | Anti-inflammatory | Corticosteroid | 5ml/10ml

  • 05

    Ketorolac Eye Drops | Anti-inflammatory | NSAID | 5ml

  • 06

    Olopatadine Eye Drops | Anti-allergic | Antihistamine | 5ml

  • 07

    Timolol Eye Drops | Antiglaucoma | Beta-blocker | 5ml

  • 08

    Latanoprost Eye Drops | Antiglaucoma | Prostaglandin analogue | 2.5ml (cold chain)

  • 09

    Dorzolamide Eye Drops | Antiglaucoma | CAI | 5ml

  • 10

    CMC Eye Drops | Lubricant | Artificial tears | 10ml/15ml

  • 11

    Cyclosporine Eye Drops | Immunomodulator | Dry eye treatment | 3ml vials

  • 12

    Tropicamide Eye Drops | Mydriatic | Cycloplegic | 5ml

We keep answer short

Frequently asked questions —
eye drop manufacturing

  • 01

    Yes. Our sterile manufacturing facility operates under WHO-GMP compliance with classified cleanroom environments — Grade A/B for aseptic fill-finish and Grade C for preparation. Water for Injection is manufactured on-site. All sterility and particulate matter testing is conducted in- house.

  • 02

    Yes — including Natamycin 5% ophthalmic suspension (antifungal for fungal keratitis), Cyclosporine ophthalmic emulsion (immunomodulator for dry eye), and Latanoprost eye drops (prostaglandin antiglaucoma) requiring cold chain storage. These specialty formulations are among the most demanded in export markets.

  • 03

    Timolol (beta-blocker), Latanoprost (prostaglandin analogue), Dorzolamide (carbonic anhydrase inhibitor) and Brimonidine (alpha-agonist) — all major classes of topical antiglaucoma medication.

  • 04

    Yes — DCGI-approved ophthalmic formulations with documentation pre-prepared for institutional tender and NHM supply submission.

  • 05

    Sterility, particulate matter (visible and sub-visible), pH, osmolality, assay, preservative content and container closure integrity — all conducted in-house before batch release.

Looking for a Eye Drops manufacturer with the compliance record to back it up?

Share your requirement - product availability, documentation and lead times confirmed within 24 hours.

Contact Us

Looking for something specific?

At 9M India Limited, trust through quality, transparency, performance.